@Anjo-Roche,
How objective do you think the opinion of someone like Professor Simmons - someone whose very academic existence and professional raison détre - would be inextricably linked to endorsing MPC technology?
I mean, you'd never find someone who is an eminent research scientist standing up and saying, "This research I'm busy with... meh, I don't think its on the right track."
Besides, the debate about whether the blood marrow trial - which received the green light to enter in Phase 3 in 2011 - is currently still "alive" today or not is rendered somewhat moot by the management's statements back in 2010, 2011 and 2012 that this was the best chance of early revenue generation and commercialisation for MSB.
The question is how a development product that offered the promise of "early revenues" more than 5 years ago, today receives no mention at all.
- Forums
- ASX - By Stock
- MSB
- Back pain stem cell injection
Back pain stem cell injection, page-66
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B |
Open | High | Low | Value | Volume |
96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 72431 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 20225 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3206 | 0.950 |
4 | 33416 | 0.945 |
4 | 35535 | 0.940 |
4 | 37778 | 0.935 |
5 | 43150 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.905 | 13161 | 1 |
0.950 | 4147 | 1 |
0.955 | 15173 | 1 |
0.960 | 26500 | 1 |
0.965 | 42426 | 3 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online